{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T20:40:26Z","timestamp":1758746426185,"version":"3.44.0"},"reference-count":57,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,10]]},"abstract":"<jats:sec>\n            <jats:title>Background.<\/jats:title>\n            <jats:p>There is a growing population of hematopoietic cell transplantation (HCT) survivors who later require a solid organ transplant (SOT). However, there are limited data on survival, risk factors (RFs) for SOT graft loss, and death.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods.<\/jats:title>\n            <jats:p>This is a retrospective Center for International Blood and Marrow Transplant Research study that included recipients of HCT followed by SOT between 2001 and 2017. HCT data were merged with data from the Organ Procurement and Transplantation Network.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results.<\/jats:title>\n            <jats:p>Eighty patients underwent autologous (45%) or allogeneic (55%) HCT followed by single SOT. Common indications for HCT included leukemia\/myelodysplastic syndrome (45%) and plasma cell disorders (38.8%). The median time from HCT to SOT was 47.7 mo. There were 49 kidney, 26 thoracic, and 5 liver transplants. Overall survival from SOT was significantly different by organ (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u20050.01). Three-year overall survival by organ type was 85% among kidney, 70.7% among thoracic, and 30% among liver SOT recipients. Significant RFs for death included lymphoma versus plasma cell disorders and SOT type; thoracic and liver SOT carried a greater risk of death than kidney SOT. There was no significant difference in SOT failure incidence by SOT type; 3-y overall incidence was 27.8%. RFs for SOT graft loss included lymphoma, liver SOT, and positive recipient cytomegalovirus status at SOT.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions.<\/jats:title>\n            <jats:p>In this study, liver SOT recipients had inferior outcomes. However, renal and thoracic SOT recipients after HCT have acceptable outcomes compared with those of the general SOT population, and thus, SOT should be considered a viable treatment option in these patients.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/tp.0000000000005397","type":"journal-article","created":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T00:00:19Z","timestamp":1750636819000},"page":"1626-1638","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Risk Factors for Solid Organ Graft Failure and Death in Hematopoietic Cell Transplant Recipients Undergoing Solid Organ Transplantation: A Retrospective Center for International Blood and Marrow Transplant Research and Organ Procurement and Transplantation Network Study"],"prefix":"10.1097","volume":"109","author":[{"given":"Meera","family":"Gupta","sequence":"first","affiliation":[{"name":"Division of Transplantation, Department of Surgery, University of Kentucky, College of Medicine, Lexington, KY."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle L.","family":"Schoettler","sequence":"additional","affiliation":[{"name":"Children\u2019s Healthcare of Atlanta, Aflac Blood and Cancer Disorder Center, Emory University, Atlanta, GA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruta","family":"Brazauskas","sequence":"additional","affiliation":[{"name":"Division of Biostatistics, Institute for Health and Equity, Medical College of Wisconsin, Milwaukee, WI."},{"name":"CIBMTR (Center for International Blood and Marrow Transplant Research), Medical College of Wisconsin, Milwaukee, WI."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie","family":"Bo-Subait","sequence":"additional","affiliation":[{"name":"CIBMTR (Center for International Blood and Marrow Transplant Research), NMDP, Minneapolis, MN."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriel","family":"Orozco","sequence":"additional","affiliation":[{"name":"Oregon Health and Science University, Portland, OR."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minoo","family":"Battiwalla","sequence":"additional","affiliation":[{"name":"Sarah Cannon Transplant and Cell Therapy Network, Nashville, TN."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Buchbinder","sequence":"additional","affiliation":[{"name":"Division of Pediatric Hematology, Children\u2019s Hospital of Orange County, Orange, CA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Betty K.","family":"Hamilton","sequence":"additional","affiliation":[{"name":"Blood and Marrow Transplant Program, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bipin N.","family":"Savani","sequence":"additional","affiliation":[{"name":"Division of Hematology\/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H\u00e9l\u00e8ne","family":"Schoemans","sequence":"additional","affiliation":[{"name":"Department of Hematology, University Hospitals Leuven, Leuven, Belgium and Department of Public Health and Primary Care, ACCENT VV, KU Leuven \u2013 University of Leuven, Leuven, Belgium."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed L.","family":"Sorror","sequence":"additional","affiliation":[{"name":"Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA."},{"name":"Department of Medicine, University of Washington School of Medicine, Seattle, WA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sairah","family":"Ahmed","sequence":"additional","affiliation":[{"name":"Department of Lymphoma\/Myeloma and Stem Cell Transplantation, University of Texas, MD Anderson Cancer Center, Houston, TX."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sherif M.","family":"Badawy","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, IL."},{"name":"Division of Hematology, Oncology, and Stem Cell Transplantation, Ann & Robert H. Lurie Children\u2019s Hospital of Chicago, Chicago, IL."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vikas","family":"Bhushan","sequence":"additional","affiliation":[{"name":"Medical City Dallas Hospital, Dallas, TX."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelly","family":"Birdsey","sequence":"additional","affiliation":[{"name":"The Colorado Blood Cancer Institute, a part of Sarah Cannon Cancer Institute at Presbyterian\/St Luke\u2019s Medical Center, Denver, CO"},{"name":"HCA Healthcare, Nashville, TN."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Couriel","sequence":"additional","affiliation":[{"name":"Transplant and Cellular Therapy Program, Huntsman Cancer Center Institute, University of Utah, Salt Lake City, UT."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erin E.","family":"Doherty","sequence":"additional","affiliation":[{"name":"Baylor College of Medicine\/Texas Children\u2019s Hospital, Houston, TX."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle","family":"Donato","sequence":"additional","affiliation":[{"name":"Hackensack University Medical Center, Hackensack, NJ."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sherif S.","family":"Farag","sequence":"additional","affiliation":[{"name":"Stem Cell Transplant and Cellular Therapy Institute, Community Health Network MD Anderson Cancer Center, Indianapolis, IN."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Gutman","sequence":"additional","affiliation":[{"name":"Division of Hematology, University of Colorado, Aurora, CO."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitchell","family":"Horwitz","sequence":"additional","affiliation":[{"name":"Duke University Medical Center, Durham, NC."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Najla","family":"El Jurdi","sequence":"additional","affiliation":[{"name":"Division of Hematology, Oncology and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph E.","family":"Maakaron","sequence":"additional","affiliation":[{"name":"Division of Hematology, Oncology and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard T.","family":"Maziarz","sequence":"additional","affiliation":[{"name":"Knight Cancer Institute, Oregon Health and Science University, Portland, OR."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis","family":"Pineiro","sequence":"additional","affiliation":[{"name":"Baylor University Medical Center, Dallas, TX."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary","family":"Schiller","sequence":"additional","affiliation":[{"name":"Hematological Malignancy\/Stem Cell Transplant Program, David Geffen School of Medicine at UCLA, Los Angeles, CA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel J.","family":"Weisdorf","sequence":"additional","affiliation":[{"name":"Division of Hematology, Oncology and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Basem M.","family":"William","sequence":"additional","affiliation":[{"name":"Ohio Health Blood and Marrow Transplant and Cell Therapy Program, Columbus, OH."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bronwen E.","family":"Shaw","sequence":"additional","affiliation":[{"name":"CIBMTR (Center for International Blood and Marrow Transplant Research), Medical College of Wisconsin, Milwaukee, WI."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel","family":"Phelan","sequence":"additional","affiliation":[{"name":"CIBMTR (Center for International Blood and Marrow Transplant Research), Medical College of Wisconsin, Milwaukee, WI."},{"name":"Division of Pediatric Hematology\/Oncology\/Blood and Marrow Transplant, Department of Pediatrics, Medical College of Wisconsin, Milwaukee, WI."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David L.","family":"Porter","sequence":"additional","affiliation":[{"name":"Center for Cell Therapy and Transplant, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter L.","family":"Abt","sequence":"additional","affiliation":[{"name":"Division of Transplantation, Department of Surgery, Hospital of the University of Pennsylvania, Philadelphia, PA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"Levine","sequence":"additional","affiliation":[{"name":"Perelman School of Medicine University of Pennsylvania and Children\u2019s Hospital of Philadelphia, Philadelphia, PA."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2025,6,23]]},"reference":[{"key":"R1-20250924","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1056\/NEJM195709122571102","article-title":"Intravenous infusion of bone marrow in patients receiving radiation and chemotherapy.","volume":"257","author":"Thomas","year":"1957","journal-title":"N Engl J Med"},{"key":"R2-20250924","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.3389\/fimmu.2019.01246","article-title":"Bone marrow transplantation 1957-2019.","volume":"10","author":"Simpson","year":"2019","journal-title":"Front Immunol"},{"key":"R3-20250924","doi-asserted-by":"crossref","first-page":"e177","DOI":"10.1016\/j.bbmt.2020.04.013","article-title":"Current use of and trends in hematopoietic cell transplantation in the United States.","volume":"26","author":"D\u2019Souza","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"key":"R4-20250924","article-title":"Summary slides and reports."},{"issue":"9 Suppl","key":"R5-20250924","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.bbmt.2008.05.017","article-title":"The national marrow donor program 20 years of unrelated donor hematopoietic cell transplantation.","volume":"14","author":"Ballen","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"key":"R6-20250924","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.bbmt.2005.11.518","article-title":"Long-term survival after blood and marrow transplantation: comparison with an age- and gender-matched normative population.","volume":"12","author":"Pond","year":"2006","journal-title":"Biol Blood Marrow Transplant"},{"key":"R7-20250924","article-title":"CIBMTR, the research program of NMDP\/be the match. One-year survival, NMDP-be the match transplants."},{"key":"R8-20250924","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1056\/NEJM199907013410103","article-title":"Long-term survival and late deaths after allogeneic bone marrow transplantation. Late Effects Working Committee of the International Bone Marrow Transplant Registry.","volume":"341","author":"Socie","year":"1999","journal-title":"N Engl J Med"},{"key":"R9-20250924","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/j.1399-3046.2004.00208.x","article-title":"Successful renal transplantation following prior bone marrow transplantation in pediatric patients.","volume":"8","author":"Thomas","year":"2004","journal-title":"Pediatr Transplant"},{"key":"R10-20250924","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/bmt.2008.207","article-title":"Contemporary analysis of the influence of acute kidney injury after reduced intensity conditioning haematopoietic cell transplantation on long-term survival.","volume":"42","author":"Lopes","year":"2008","journal-title":"Bone Marrow Transplant"},{"key":"R11-20250924","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.bbmt.2007.12.492","article-title":"Impact of acute kidney injury on long-term mortality after nonmyeloablative hematopoietic cell transplantation.","volume":"14","author":"Parikh","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"key":"R12-20250924","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1111\/ajt.13017","article-title":"Allogeneic hematopoietic stem cell transplantation in solid organ transplant recipients: a retrospective, multicenter study of the EBMT.","volume":"15","author":"Basak","year":"2015","journal-title":"Am J Transplant"},{"key":"R13-20250924","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1111\/j.1600-6143.2010.03187.x","article-title":"Solid organ transplantation after allogeneic hematopoietic stem cell transplantation: a retrospective, multicenter study of the EBMT.","volume":"10","author":"Koenecke","year":"2010","journal-title":"Am J Transplant"},{"key":"R14-20250924","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1111\/ajt.15240","article-title":"Solid organ transplantation after hematopoietic stem cell transplantation in childhood: a multicentric retrospective survey.","volume":"19","author":"Faraci","year":"2019","journal-title":"Am J Transplant"},{"author":"Auletta","key":"R15-20250924","article-title":"Current use and outcome of hematopoietic stem cell transplantation: CIBMTR US summary slides."},{"key":"R16-20250924","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1093\/jnci\/djaa022","article-title":"Conditional survival, cause-specific mortality, and risk factors of late mortality after allogeneic hematopoietic cell transplantation.","volume":"112","author":"Wong","year":"2020","journal-title":"J Natl Cancer Inst"},{"key":"R17-20250924","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1097\/TP.0000000000005377","article-title":"Risk factors for solid organ graft failure and death in solid organ transplant recipients undergoing hematopoietic cell transplantation: a retrospective Center for International Blood and Marrow Transplant Research (CIBMTR) and Organ Procurement and Transplantation Network (OPTN) study.","volume":"109","author":"Gupta","year":"2025","journal-title":"Transplantation"},{"key":"R18-20250924","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1038\/s41409-018-0204-7","article-title":"EBMT-NIH-CIBMTR Task Force position statement on standardized terminology and guidance for graft-versus-host disease assessment.","volume":"53","author":"Schoemans","year":"2018","journal-title":"Bone Marrow Transplant"},{"key":"R19-20250924","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.3389\/fimmu.2020.02017","article-title":"Autoimmunity following allogeneic hematopoietic stem cell transplantation.","volume":"11","author":"Buxbaum","year":"2020","journal-title":"Front Immunol"},{"key":"R20-20250924","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1200\/JCO.1984.2.3.187","article-title":"Karnofsky performance status revisited: reliability, validity, and guidelines.","volume":"2","author":"Schag","year":"1984","journal-title":"J Clin Oncol"},{"key":"R21-20250924","article-title":"optn-star-files-data-dictionary.xlsx (live.com)."},{"key":"R22-20250924","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1182\/blood-2005-05-2004","article-title":"Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT.","volume":"106","author":"Sorror","journal-title":"Blood"},{"key":"R25-20250924","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/s41409-018-0255-9","article-title":"Solid organ transplantation following allogeneic haematopoietic cell transplantation: experience from a referral organ transplantation center and systematic review of literature.","volume":"54","author":"Brockmann","year":"2019","journal-title":"Bone Marrow Transplant"},{"key":"R26-20250924","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.bbmt.2014.12.031","article-title":"NIH Consensus development project on criteria for clinical trials in chronic graft-versus-host disease: II. The 2014 Pathology Working Group Report.","volume":"21","author":"Shulman","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"R27-20250924","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1182\/blood-2010-03-258608","article-title":"Kidney disease associated with plasma cell dyscrasias.","volume":"116","author":"Heher","year":"2010","journal-title":"Blood"},{"key":"R28-20250924","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1681\/ASN.2021111488","article-title":"Hematopoietic stem cell transplant-membranous nephropathy is associated with protocadherin FAT1.","volume":"33","author":"Sethi","year":"2022","journal-title":"J Am Soc Nephrol"},{"key":"R29-20250924","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1034\/j.1399-0012.1999.130409.x","article-title":"Renal transplantation for end-stage renal disease following bone marrow transplantation: a report of six cases, with and without immunosuppression.","volume":"13","author":"Butcher","year":"2001","journal-title":"J Clin Transplant"},{"key":"R30-20250924","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s12882-018-0855-z","article-title":"Membranous nephropathy succeeding autologous hematopoietic stem cell transplant: a case report.","volume":"19","author":"Mrabet","year":"2018","journal-title":"BMC Nephrol"},{"key":"R31-20250924","doi-asserted-by":"crossref","first-page":"E19","DOI":"10.1053\/ajkd.2002.36930","article-title":"Membranoproliferative glomerulonephritis develops in a child with autologous stem cell transplant.","volume":"40","author":"Sakarcan","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"R32-20250924","first-page":"503","article-title":"Nephrotic syndrome in a bone marrow transplant recipient without chronic graft-versus-host disease.","volume":"99","author":"Chien","year":"2000","journal-title":"J Formos Med Assoc"},{"key":"R33-20250924","article-title":"Data reports: national data."},{"key":"R34-20250924","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.bbmt.2007.05.001","article-title":"Bronchiolitis obliterans syndrome (BOS), bronchiolitis obliterans organizing pneumonia (BOOP), and other late-onset noninfectious pulmonary complications following allogeneic hematopoietic stem cell transplantation.","volume":"13","author":"Yoshihara","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"issue":"Suppl 4","key":"R35-20250924","first-page":"S19","article-title":"The lung as a critical organ in marrow transplantation.","volume":"14","author":"Quabeck","year":"1994","journal-title":"Bone Marrow Transplant"},{"key":"R36-20250924","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1111\/trf.13415","article-title":"Blood transfusions and pulmonary complications after hematopoietic cell transplantation.","volume":"56","author":"Solh","year":"2016","journal-title":"Transfusion"},{"journal-title":"Pathophysiology of lung injury after hematopoietic stem cell transplantation","year":"2004","author":"Cooke","key":"R37-20250924"},{"key":"R38-20250924","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1111\/ctr.12378","article-title":"Lung transplantation following hematopoietic stem cell transplantation: report of two cases and systematic review of literature.","volume":"28","author":"Soubani","year":"2014","journal-title":"Clin Transplant"},{"key":"R39-20250924","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1164\/rccm.200212-1468OC","article-title":"Airflow obstruction after myeloablative allogeneic hematopoietic stem cell transplantation.","volume":"168","author":"Chien","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"R40-20250924","doi-asserted-by":"crossref","first-page":"648","DOI":"10.7326\/0003-4819-107-5-648","article-title":"Risk factors for airflow obstruction in recipients of bone marrow transplants.","volume":"107","author":"Clark","year":"1987","journal-title":"Ann Intern Med"},{"key":"R41-20250924","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1378\/chest.128.1.153","article-title":"Risk factors for bronchiolitis obliterans in allogeneic hematopoietic stem-cell transplantation for leukemia.","volume":"128","author":"Santo Tomas","year":"2005","journal-title":"Chest"},{"key":"R42-20250924","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/00005792-199809000-00005","article-title":"Outcomes of recipients of both bone marrow and solid organ transplants. A review.","volume":"77","author":"Dey","year":"1998","journal-title":"Medicine (Baltimore)"},{"issue":"12","key":"R43-20250924","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1097\/00042737-200412000-00019","article-title":"Liver disease is a major cause of mortality following allogeneic bone-marrow transplantation.","volume":"16","author":"El-Sayed","year":"2004","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R44-20250924","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/j.1399-0012.2008.00814.x","article-title":"Liver transplantation for sinusoidal obstructive syndrome (veno-occlusive disease): case report with review of the literature and the UNOS database.","volume":"22","author":"Membreno","year":"2008","journal-title":"Clin Transplant"},{"key":"R45-20250924","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/sj.bmt.1703688","article-title":"Organ tolerance following cadaveric liver transplantation for chronic graft-versus-host disease after allogeneic bone marrow transplantation.","volume":"30","author":"Urban","year":"2002","journal-title":"Bone Marrow Transplant"},{"key":"R46-20250924","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1097\/00007890-199004000-00035","article-title":"Successful treatment of hepatic venoocclusive disease in a bone marrow transplant patient with orthotopic liver transplantation.","volume":"49","author":"Nimer","year":"1990","journal-title":"Transplantation"},{"key":"R47-20250924","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/0016-5085(90)91039-9","article-title":"Orthotopic liver transplantation for graft-versus-host disease following bone marrow transplantation.","volume":"99","author":"Rhodes","year":"1990","journal-title":"Gastroenterology"},{"key":"R48-20250924","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/lt.500020308","article-title":"Orthotopic liver transplantation for bone-marrow transplant-associated veno-occlusive disease and graft-versus-host disease of the liver.","volume":"2","author":"Rosen","year":"1996","journal-title":"Liver Transpl Surg"},{"key":"R49-20250924","first-page":"473","article-title":"Allogeneic liver transplantation for hepatic veno-occlusive disease after bone marrow transplantation\u2014clinical and immunological considerations.","volume":"16","author":"Schlitt","year":"1995","journal-title":"Bone Marrow Transplant"},{"key":"R50-20250924","first-page":"421","article-title":"Orthotopic liver transplantation for life-threatening veno-occlusive disease of the liver after allogeneic bone marrow transplant.","volume":"8","author":"Rapoport","year":"1991","journal-title":"Bone Marrow Transplant"},{"key":"R51-20250924","first-page":"463","article-title":"Orthotopic liver transplantation for hepatic GVHD following allogeneic BMT for chronic myeloid leukaemia.","volume":"10","author":"Marks","year":"1992","journal-title":"Bone Marrow Transplant"},{"key":"R52-20250924","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/SLA.0000000000001383","article-title":"Defining long-term outcomes with living donor liver transplantation in North America.","volume":"262","author":"Olthoff","year":"2015","journal-title":"Ann Surg"},{"key":"R53-20250924","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1111\/j.1600-6143.2005.01225.x","article-title":"Donor kidney volume and outcomes following live donor kidney transplantation.","volume":"6","author":"Poggio","year":"2006","journal-title":"Am J Transplant"},{"key":"R54-20250924","article-title":"Current use and outcome of hematopoietic stem cell transplantation: CIBMTR US summary slides."},{"issue":"Suppl 4","key":"R55-20250924","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/ajt.12103","article-title":"Cytomegalovirus in solid organ transplantation.","volume":"13","author":"Razonable","year":"2013","journal-title":"Am J Transplant"},{"key":"R56-20250924","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1097\/TP.0000000000002191","article-title":"The Third International Consensus Guidelines on the management of cytomegalovirus in solid-organ transplantation.","volume":"102","author":"Kotton","year":"2018","journal-title":"Transplantation"},{"key":"R57-20250924","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1086\/528718","article-title":"Delayed-onset primary cytomegalovirus disease and the risk of allograft failure and mortality after kidney transplantation.","volume":"46","author":"Arthurs","year":"2008","journal-title":"Clin Infect Dis"},{"key":"R58-20250924","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1086\/324516","article-title":"Allograft rejection predicts the occurrence of late-onset cytomegalovirus (CMV) disease among CMV-mismatched solid organ transplant patients receiving prophylaxis with oral ganciclovir.","volume":"184","author":"Razonable","year":"2001","journal-title":"J Infect Dis"},{"key":"R59-20250924","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1093\/ndt\/gfz268","article-title":"Revisiting cytomegalovirus serostatus and replication as risk factors for inferior long-term outcomes in the current era of renal transplantation.","volume":"35","author":"Bischof","year":"2020","journal-title":"Nephrol Dial Transplant"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000005397","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T20:01:24Z","timestamp":1758744084000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000005397"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,23]]},"references-count":57,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000005397","relation":{},"ISSN":["0041-1337","1534-6080"],"issn-type":[{"type":"print","value":"0041-1337"},{"type":"electronic","value":"1534-6080"}],"subject":[],"published":{"date-parts":[[2025,6,23]]}}}